| http://dbpedia.org/ontology/abstract
|
Algeta ASA (ALGETA:NO) was founded in 1997 … Algeta ASA (ALGETA:NO) was founded in 1997 by Roy H. Larsen and Øyvind S. Bruland in Oslo, Norway as a private biotechnology and pharmaceutical company. The company’s research and development focus lies in the field of alpha-particle emitting radiopharmaceuticals. The lead product of the company, Xofigo is the first marketed alpha-particle emitting radiopharmaceutics for cancer treatment.g radiopharmaceutics for cancer treatment.
|
| http://dbpedia.org/ontology/foundingYear
|
1997
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Norway +
, http://dbpedia.org/resource/Oslo +
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Xofigo +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Bayer_AG +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.bloomberg.com/quote/ALGETA:NO +
, http://www.bayer.no +
|
| http://dbpedia.org/ontology/wikiPageID
|
43190981
|
| http://dbpedia.org/ontology/wikiPageLength
|
6298
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1113702832
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_Norway +
, http://dbpedia.org/resource/Overall_survival +
, http://dbpedia.org/resource/Prostate_cancer +
, http://dbpedia.org/resource/Radiopharmaceuticals +
, http://dbpedia.org/resource/Mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1997 +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/HealthCap +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Saline_%28medicine%29 +
, http://dbpedia.org/resource/Pharmaceutical_company +
, http://dbpedia.org/resource/Hydroxyapatite +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Bone_metastases +
, http://dbpedia.org/resource/Calcium +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Bayer_AG +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Norway +
, http://dbpedia.org/resource/Xofigo +
, http://dbpedia.org/resource/Radium-223 +
, http://dbpedia.org/resource/Oslo +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:1997_establishments_in_Norway +
, http://dbpedia.org/resource/Oslo_Stock_Exchange +
, http://dbpedia.org/resource/Norway +
, http://dbpedia.org/resource/Alpha-particle +
|
| http://dbpedia.org/property/foundation
|
1997
|
| http://dbpedia.org/property/homepage
|
http://www.bayer.no +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Norway +
, http://dbpedia.org/resource/Oslo +
|
| http://dbpedia.org/property/name
|
Algeta ASA
|
| http://dbpedia.org/property/products
|
http://dbpedia.org/resource/Xofigo +
|
| http://dbpedia.org/property/type
|
Acquired by Bayer AG in December 2013
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Authority_control +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Norway +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Norway +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:1997_establishments_in_Norway +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
|
| http://schema.org/sameAs
|
http://viaf.org/viaf/1153149368827185980006 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Algeta?oldid=1113702832&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.bayer.no +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Algeta +
|
| http://xmlns.com/foaf/0.1/name
|
Algeta ASA
|
| owl:sameAs |
http://rdf.freebase.com/ns/m.0113kx8c +
, http://viaf.org/viaf/1153149368827185980006 +
, http://www.wikidata.org/entity/Q17304559 +
, https://global.dbpedia.org/id/gbGL +
, http://dbpedia.org/resource/Algeta +
, http://yago-knowledge.org/resource/Algeta +
, http://no.dbpedia.org/resource/Algeta +
|
| rdf:type |
http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.wikidata.org/entity/Q24229398 +
|
| rdfs:comment |
Algeta ASA (ALGETA:NO) was founded in 1997 … Algeta ASA (ALGETA:NO) was founded in 1997 by Roy H. Larsen and Øyvind S. Bruland in Oslo, Norway as a private biotechnology and pharmaceutical company. The company’s research and development focus lies in the field of alpha-particle emitting radiopharmaceuticals. The lead product of the company, Xofigo is the first marketed alpha-particle emitting radiopharmaceutics for cancer treatment.g radiopharmaceutics for cancer treatment.
|
| rdfs:label |
Algeta
|
